BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8647589)

  • 1. High-frequency oscillatory ventilation and nitric oxide: alternative or complementary to ECMO.
    Kachel W; Varnholt V; Lasch P; Müller W; Lorenz C; Wirth H
    Int J Artif Organs; 1995 Oct; 18(10):589-97. PubMed ID: 8647589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The role of extracorporeal membrane oxygenation (ECMO) in current neonatology].
    Kachel W; Lasch P; Varnholt V; Wirth H; Quintel M
    Z Geburtshilfe Neonatol; 1997; 201 Suppl 1():68-76. PubMed ID: 9410532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn.
    Kinsella JP; Truog WE; Walsh WF; Goldberg RN; Bancalari E; Mayock DE; Redding GJ; deLemos RA; Sardesai S; McCurnin DC; Moreland SG; Cutter GR; Abman SH
    J Pediatr; 1997 Jul; 131(1 Pt 1):55-62. PubMed ID: 9255192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased use of neonatal extracorporeal membrane oxygenation (ECMO): how new treatment modalities have affected ECMO utilization.
    Hintz SR; Suttner DM; Sheehan AM; Rhine WD; Van Meurs KP
    Pediatrics; 2000 Dec; 106(6):1339-43. PubMed ID: 11099586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of new treatments for respiratory failure on outcome of infants with congenital diaphragmatic hernia.
    Somaschini M; Locatelli G; Salvoni L; Bellan C; Colombo A
    Eur J Pediatr; 1999 Oct; 158(10):780-4. PubMed ID: 10486074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of new treatments for neonatal pulmonary hypertension on extracorporeal membrane oxygenation use and outcome.
    Kennaugh JM; Kinsella JP; Abman SH; Hernandez JA; Moreland SG; Rosenberg AA
    J Perinatol; 1997; 17(5):366-9. PubMed ID: 9373841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do we need new indications for ECMO in neonates pretreated with high-frequency ventilation and/or inhaled nitric oxide?
    Kössel H; Bauer K; Kewitz G; Karaca S; Versmold H
    Intensive Care Med; 2000 Oct; 26(10):1489-95. PubMed ID: 11126261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactive effects of high-frequency oscillatory ventilation and inhaled nitric oxide in acute hypoxemic respiratory failure in pediatrics.
    Dobyns EL; Anas NG; Fortenberry JD; Deshpande J; Cornfield DN; Tasker RC; Liu P; Eells PL; Griebel J; Kinsella JP; Abman SH
    Crit Care Med; 2002 Nov; 30(11):2425-9. PubMed ID: 12441749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapted ECMO criteria for newborns with persistent pulmonary hypertension after inhaled nitric oxide and/or high-frequency oscillatory ventilation.
    van Berkel S; Binkhorst M; van Heijst AF; Wijnen MH; Liem KD
    Intensive Care Med; 2013 Jun; 39(6):1113-20. PubMed ID: 23580134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical effect of combination therapy with high-frequency oscillation ventilation, pulmonary surfactant and inhaled nitric oxide in the treatment of neonatal hypoxemic respiratory failure].
    Lin XZ; Zheng Z; Li YD; Lai JD; Yao LS; Lan ZY; Huang J; Lin YY; Chen PH; Chen HQ
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec; 15(12):1068-73. PubMed ID: 24342198
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of failure of high-frequency oscillatory ventilation in term infants with severe respiratory failure.
    Paranka MS; Clark RH; Yoder BA; Null DM
    Pediatrics; 1995 Mar; 95(3):400-4. PubMed ID: 7862480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of Preterm Neonates with a Birth Weight <1,500 g with Severe Hypoxemic Respiratory Failure Rescued by Inhaled Nitric Oxide Therapy and High-Frequency Oscillatory Ventilation.
    Golfar A; Bhogal J; Kamstra B; Hudson-Mason A; Qureshi M; Schmölzer GM; Cheung PY
    Neonatology; 2017; 112(3):274-280. PubMed ID: 28704817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent and combined effects of inhaled nitric oxide, liquid perfluorochemical, and high-frequency oscillatory ventilation in premature lambs with respiratory distress syndrome.
    Kinsella JP; Parker TA; Galan H; Sheridan BC; Abman SH
    Am J Respir Crit Care Med; 1999 Apr; 159(4 Pt 1):1220-7. PubMed ID: 10194169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive therapies for treatment of severe respiratory failure in newborns.
    Patry C; Hien S; Demirakca S; Reinhard J; Majorek M; Brade J; Schaible T
    Klin Padiatr; 2015 Jan; 227(1):28-32. PubMed ID: 25565196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure.
    Konduri GG; Solimano A; Sokol GM; Singer J; Ehrenkranz RA; Singhal N; Wright LL; Van Meurs K; Stork E; Kirpalani H; Peliowski A;
    Pediatrics; 2004 Mar; 113(3 Pt 1):559-64. PubMed ID: 14993550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictability model of the need for extracorporeal membrane oxygenation in neonates with meconium aspiration syndrome treated with inhaled nitric oxide.
    Friedlich P; Noori S; Stein J; Shin C; Burns C; Ramanathan R; Seri I
    J Pediatr Surg; 2005 Jul; 40(7):1090-3. PubMed ID: 16034750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of inhaled nitric oxide on the course of extracorporeal membrane oxygenation and the occurrence of hemorrhagic complications.
    de Mol AC; van Heijst AF; de Haan TF; van der Staak FH; Liem KD
    ASAIO J; 2009; 55(3):213-6. PubMed ID: 19293708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn.
    Wessel DL; Adatia I; Van Marter LJ; Thompson JE; Kane JW; Stark AR; Kourembanas S
    Pediatrics; 1997 Nov; 100(5):E7. PubMed ID: 9347001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhaled nitric oxide: current and future uses in neonates.
    Kinsella JP; Abman SH
    Semin Perinatol; 2000 Dec; 24(6):387-95. PubMed ID: 11153900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of severe non-neonatal ARDS in children with surfactant and nitric oxide in a "pre-ECMO"-situation.
    Möller JC; Schaible TF; Reiss I; Artlich A; Gortner L
    Int J Artif Organs; 1995 Oct; 18(10):598-602. PubMed ID: 8647590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.